Glenview Capital Management — TEVA Trade History
Quarter-by-quarter changes in the TEVA PHARMACEUTICAL INDS LTD position · CUSIP 881624209
Currently held · 2.8 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 5,081,091 | -1,579,129 | -23.7% | $172.1M | 3.13% |
| 2026 Q1 | 2026-05-15 | Reduce | 6,660,220 | -10,059,989 | -60.2% | $200.6M | 5.04% |
| 2025 Q4 | 2026-02-17 | Add | 16,720,209 | 27,529 | +0.2% | $521.8M | 10.62% |
| 2025 Q3 | 2025-11-14 | Add | 16,692,680 | 868,457 | +5.5% | $337.2M | 7.51% |
| 2025 Q2 | 2025-08-14 | Add | 15,824,223 | 1,045,582 | +7.1% | $265.2M | 7.43% |
| 2025 Q1 | 2025-05-15 | Add | 14,778,641 | 6,322,317 | +74.8% | $227.1M | 5.58% |
| 2024 Q4 | 2025-02-14 | Hold | 8,456,324 | — | 0.0% | $186.4M | 4.71% |
| 2024 Q3 | 2024-11-14 | Reduce | 8,456,324 | -701,317 | -7.7% | $152.4M | 2.95% |
| 2024 Q2 | 2024-08-14 | Add | 9,157,641 | 1,656,357 | +22.1% | $148.8M | 2.93% |
| 2024 Q1 | 2024-05-15 | Add | 7,501,284 | 5,896,651 | +367.5% | $105.8M | 1.85% |
| 2023 Q4 | 2024-02-14 | New | 1,604,633 | 1,604,633 | — | $16.8M | 0.36% |
| 2023 Q3 | 2023-11-14 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-14 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-15 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-11 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q2 | 2022-02-18 | — | — | — | — | — | — |
| 2021 Q3 | 2022-02-18 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-14 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-15 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-14 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-14 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | Sold out | — | -2,176,144 | -100.0% | — | — |
| 2016 Q3 | 2016-11-14 | New | 2,176,144 | 2,176,144 | — | $100.1M | 0.72% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.